tiprankstipranks
Atrium Therapeutics, Inc. (RNA)
NASDAQ:RNA
US Market
RNA
Atrium Therapeutics, Inc.
RESEARCH TOOLSreports

Atrium Therapeutics, Inc. (RNA) Cash flow

6 Followers

Atrium Therapeutics, Inc. Cash Flow

RNA's free cash flow for Q4 2025 was $-20.13M. For the 2025 fiscal year, RNA's free cash flow was decreased by $265.36M and operating cash flow was $-19.25M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
$ -41.13M$ -300.87M$ -119.06M$ -136.27M$ -94.81M
Investing Cash Flow
$ -1.45M$ -854.20M$ -130.07M$ -189.96M$ -82.52M
Financing Cash Flow
$ 42.57M$ 1.19B$ 93.86M$ 346.17M$ 176.32M
End Cash Position
$ 0.00$ 222.66M$ 185.38M$ 340.65M$ 320.70M
Free Cash Flow
$ -42.57M$ -307.94M$ -123.29M$ -139.09M$ -98.55M
Currency in USD

Atrium Therapeutics, Inc. Cash Flow